{
  "response": {
    "text": "The clinical trial ID for the study \"Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial\" is NCT02958111.\n",
    "citations": [
      "https://fr.wikipedia.org/wiki/Cap%C3%A9citabine"
    ]
  }
}